Zobrazeno 1 - 10
of 17
pro vyhledávání: '"G. Jamero"'
Autor:
G. Jamero, J. Patel, M. Kittleson, T. Singer-Englar, N. Patel, S. Kim, A. Nikolova, F. Esmailian, L. Czer, J.A. Kobashigawa
Publikováno v:
The Journal of Heart and Lung Transplantation. 41:S202
Autor:
A. Velleca, M. Kittleson, J. Patel, T. Singer-Englar, N. Patel, C. Washington, G. Jamero, L. Czer, F. Esmailian, P. Zakowski, J.A. Kobashigawa
Publikováno v:
The Journal of Heart and Lung Transplantation. 41:S342
Autor:
G. Jamero, F. De Leon, M. Ackerman, M. Welton, N. Kissling, A. Velleca, M. White, L. Czer, A. Nikolova, E. Kransdorf, D. Chang, M. Kittleson, J. Patel, J.A. Kobashigawa
Publikováno v:
The Journal of Heart and Lung Transplantation. 41:S403
Autor:
Jignesh Patel, Jon A. Kobashigawa, T. Singer-Englar, Antoine Hage, Evan P. Kransdorf, G. Jamero, D. Megna, M. Froch, N. Patel, Michelle M. Kittleson, Lawrence S.C. Czer
Publikováno v:
The Journal of Heart and Lung Transplantation. 40:S133-S134
Purpose Monotherapy with tacrolimus alone (TAC-A) was found to be safe and effective in the TICTAC Trial. However, in that trial, tacrolimus levels were maintained at 10-12 ng/mL over the first year which resulted in a higher serum creatinine level c
Autor:
G. Jamero, Danny Ramzy, M. Ackerman, David Chang, T. Singer-Englar, Jon A. Kobashigawa, Michelle M. Kittleson, N. Patel, Evan P. Kransdorf, Jignesh Patel, Lawrence S.C. Czer
Publikováno v:
The Journal of Heart and Lung Transplantation. 40:S201
Purpose Chronic kidney disease after heart transplantation is not uncommon due to the nephrotoxicity of calcineurin inhibitors (CNIs). It is well established that kidney dysfunction does impact post-transplant survival. What is not known is whether e
Autor:
Jon A. Kobashigawa, M. Oda, Evan P. Kransdorf, Jignesh Patel, Cyril R. Gaultier, Michelle M. Kittleson, Fardad Esmailian, T. Singer-Englar, G. Jamero, David Chang, N. Patel, P. Zakowski, R. Zabner
Publikováno v:
The Journal of Heart and Lung Transplantation. 40:S233
Purpose Chagas disease (CD) is caused by the parasite T cruzi and may reactivate in immunosuppressed transplant recipients. The incidence of CD has increased in Southern California as patients with Chagas cardiomyopathy may progress to require heart
Autor:
D. Melamed, G. Jamero, Jon A. Kobashigawa, Jignesh Patel, Evan P. Kransdorf, A. Shen, Babak Azarbal, Michelle M. Kittleson, Lawrence S.C. Czer, Alfredo Trento, David Chang, K. Nishihara, Danny Ramzy
Publikováno v:
The Journal of Heart and Lung Transplantation. 39:S298
Autor:
A. Shen, K. Nishihara, Michelle M. Kittleson, Jignesh Patel, D. Megna, Antoine Hage, G. Jamero, Jon A. Kobashigawa, Evan P. Kransdorf, Babak Azarbal, Lawrence S.C. Czer
Publikováno v:
The Journal of Heart and Lung Transplantation. 39:S273
Purpose The development of donor specific antibody (DSA) after heart transplantation has been associated with increased development of cardiac allograft vasculopathy (CAV). Steroid weaning has been popular among heart transplant programs, however, it
Autor:
G. Jamero, Jignesh Patel, Michelle M. Kittleson, Danny Ramzy, Fardad Esmailian, David Chang, Jon A. Kobashigawa, K. Nishihara, Evan P. Kransdorf, Lawrence S.C. Czer, A. Shen, Bernice Coleman
Publikováno v:
The Journal of Heart and Lung Transplantation. 39:S275
Purpose Sensitized patients awaiting heart transplantation (HTx) are at increased risk for mortality as their waitlist time is lengthened due to incompatible donors and a subsequently narrowed donor pool. Therefore, these patients undergo desensitiza
Autor:
David Chang, Danny Ramzy, Jignesh Patel, G. Jamero, Jon A. Kobashigawa, Tamar Aintablian, Evan P. Kransdorf, Dael Geft, Michelle M. Kittleson, Lawrence S.C. Czer, L. Arakawa
Publikováno v:
The Journal of Heart and Lung Transplantation. 36:S301